These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 10599358)

  • 1. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): electrocardiographic substudy--three months follow-up.
    Paulisiński R; Chibowska M; Biłan A; Ostrowski S; Weglarz J; Krasowska D; Hanzlik J
    Adv Exp Med Biol; 1999; 455():295-8. PubMed ID: 10599358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): ECG exercise testing--three months follow-up.
    Biłan A; Chibowska M; Palusiński R; Witczak A; Ostrowski S; Makaruk B; Weglarz J; Hanzlik J; Krasowska D
    Adv Exp Med Biol; 1999; 455():285-8. PubMed ID: 10599356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): pulmonary substudy--effects of three month treatment.
    Ostrowski S; Chibowska M; Biłan A; Palusiński R; Weglarz J; Makaruk B; Krasowska D; Hanzlik J
    Adv Exp Med Biol; 1999; 455():289-93. PubMed ID: 10599357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): echocardiographic substudy--three months follow-up.
    Biłan A; Chibowska M; Makaruk B; Palusiński R; Weglarz J; Ostrowski S; Witczak A; Hanzlik J; Krasowska D
    Adv Exp Med Biol; 1999; 455():279-83. PubMed ID: 10599355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
    Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
    Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor].
    Durruty P; Tapia JC; Ugarte C; Pérez E; Krause P; Soto N; García de los Ríos M
    Rev Med Chil; 1996 Sep; 124(9):1036-44. PubMed ID: 9197016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
    Rake EC; Breeze E; Fletcher AE
    J Hum Hypertens; 2001 Dec; 15(12):863-7. PubMed ID: 11773989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M; Lang R; Rachmani R; Lishner M
    Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
    Boman KO; Jansson JH; Nyhlén KA; Nilsson TK
    Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recording of atrial and ventricular signal averaged ECGs in patients with mitral valve prolapse syndrome].
    Banasiak W; Pajak I; Ponikowski P; Wiech K; Lacheta W; Telichowski C
    Pol Merkur Lekarski; 1998 Jun; 4(24):302-5. PubMed ID: 9771010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The comparison of the effect of enalapril and indapamide on the peripheral blood pressure and central blood pressure through pulse wave analysis].
    Jiang XJ; Li QY; Zhang YQ; Liu GZ; Liu LS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):885-8. PubMed ID: 16266472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term tolerability of enalapril in hypertensive patients with renal impairment.
    Keane WF; Polis A; Wolf D; Faison E; Shahinfar S
    Nephrol Dial Transplant; 1997; 12 Suppl 2():75-81. PubMed ID: 9269706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of signal-averaging electrocardiographic systems using device specific criteria in 104 normal subjects.
    Moreno FL; Karagounis LA; Villanueva T; Horn SD; Anderson JL
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2178-82. PubMed ID: 7845839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
    Applegate W; Cohen JD; Wolfson P; Davis A; Green S
    Pharmacotherapy; 1997; 17(1):107-12. PubMed ID: 9017770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral enalapril in patients with symptomatic ventricular septal defects].
    Vázquez-Antona CA; Simón Ruiz S; Rijlaarsdam M; Miranda Chávez I; Leiva JL; Buendía A; Attie F
    Arch Inst Cardiol Mex; 1996; 66(6):496-504. PubMed ID: 9133310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of filtering techniques on time-domain analysis of signal-averaged ECG after acute myocardial infarction: a multicenter study, GISS-3 arrhythmia sub-project].
    Del Greco M; Nollo G; Disertori M; Sanna G; Maggioni AP; Santoro E; Tarantino F; Della Mea MT; Antolini R; Micciolo R
    G Ital Cardiol; 1996 Jan; 26(1):73-84. PubMed ID: 8682263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.